Find your path to Bart
81 people in our graph can introduce you to Bart.
Each arrow is one introduction. Sign up to fill in the first one.
Ask Michiel Klaps to introduce you to Bart
You →Michiel · together at Fortino Capital (2019) →Bart
Ask Jamie Chen to introduce you to Bart
You →Jamie · 2 people · together at Fortino Capital →Bart
Ask Sam Okafor to introduce you to Bart
You →Sam · 7 people · together at BNP Paribas Fortis →Bart
Sign up to find every way you can get introduced to Bart
- Your email: the people you already email who know Bart
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with Bart
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
About
Joined Fund+ in 2023 as Partner & CFO. He previously served as CFO and Risk Officer at Fortino Capital Partners and held finance roles at Ackermans & van Haaren and Ernst & Young. He sits on the boards of several therapeutics companies including Coave, EPICS, EyeD Pharmaceuticals, Minoryx and Novadip Biosciences.
Contact· self-published, not guessed
Experience
- FundPlusPartnercurrent2023 — present
- EyeD PharmaBoard Membercurrent2023 — presentLiege Metropolitan Area
- UniD ManufacturingBoard Membercurrent2023 — presentLiege Metropolitan Area
- Coave TherapeuticsBoard Membercurrent2023 — presentGreater Paris Metropolitan Region
- EPICS TherapeuticsBoard Membercurrent2024 — presentGosselies
- WOLLUXCEO2021 — 2023Kortrijk, Flemish Region, Belgium
- Koramic Visual CommunicationMember Of The Management Board2021 — 2023Mouscron, Walloon Region, Belgium
- Fortino Capital PartnersCFO2019 — 2020Antwerpen Berchem, Vlaanderen, België
- Ackermans & van HaarenFinance2016 — 2019
- Ernst&YoungIFRS2002 — 2016
- Wolters Kluwer Financial Services | FinArchBusiness Consultant2000 — 2002Greater Boston
- BNP Paribas FortisConsolidatie1996 — 2000
Skills & more
+1 more
Internal AuditFrom Bart's professional profile.
Colleagues at Fund+
Frequently asked questions
- Who is Bart De Leeuw?
- Joined Fund+ in 2023 as Partner & CFO. He previously served as CFO and Risk Officer at Fortino Capital Partners and held finance roles at Ackermans & van Haaren and Ernst & Young. He sits on the boards of several therapeutics companies including Coave, EPICS, EyeD Pharmaceuticals, Minoryx and Novadip Biosciences.
- Where does Bart De Leeuw work?
- Bart De Leeuw is Partner/CFO at Fund+.
- Where did Bart De Leeuw go to school?
- Bart De Leeuw studied at HUB-KUBrussel.
Same school
Also attended HUB-KUBrussel1
Shared employers
Also worked at EyeD Pharma5
Also worked at Coave Therapeutics6
Also worked at Ernst&Young2,000
+ 1,994 more
Also worked at BNP Paribas Fortis57
+ 51 more








































